Dostarlimab, Loncastuximab tesirine, & HER2 GI Updates
May 06, 2021•17 min
Episode description
Two brand new drugs to discuss and their possible roles in practice. Plus, updates on the treatment of HER2-amplified gastric cancer and colorectal cancer.
For the best experience, listen in Metacast app for iOS or Android
